|
A study comparing the efficacy, safety, and tolerability of an investigational drug versus placebo or Ropinirole in patients with early Parkinson's Disease Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or professional assistance by using a genuine doctor. We aren't mDs. Always consult your physician about A study comparing the efficacy, safety, and tolerability of an investigational drug versus placebo or Ropinirole in patients with early Parkinson's Disease conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. A study comparing the efficacy, safety, and tolerability of an investigational drug versus placebo or Ropinirole in patients with early Parkinson's Disease Clinical research trials and A study comparing the efficacy, safety, and tolerability of an investigational drug versus placebo or Ropinirole in patients with early Parkinson's Disease health trials occur in a lot of of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the potency of new does drugs. The role of the studies / undertakings is to figure out specific human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all sorts of conditions, including A study comparing the efficacy, safety, and tolerability of an investigational drug versus placebo or Ropinirole in patients with early Parkinson's Disease. A study comparing the efficacy, safety, and tolerability of an investigational drug versus placebo or Ropinirole in patients with early Parkinson's Disease Clinical Trials and other clinical trials permit volunteers to get medical treatment choices before they are available to the general public. Many times the test subjects get professional assistance for free of charge, and occasionally they are compensated for their time. Sometimes there is a cost for a A study comparing the efficacy, safety, and tolerability of an investigational drug versus placebo or Ropinirole in patients with early Parkinson's Disease clinical trial. Human subjects often get the best healthcare possible for their A study comparing the efficacy, safety, and tolerability of an investigational drug versus placebo or Ropinirole in patients with early Parkinson's Disease condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, medical hazards (perhaps life-threatening), and/or the treatment being ineffectual. Trials are federally governed with exacting guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A study comparing the efficacy, safety, and tolerability of an investigational drug versus placebo or Ropinirole in patients with early Parkinson's Disease A study comparing the efficacy, safety, and tolerability of an investigational drug versus placebo or Ropinirole in patients with early Parkinson's Disease
A study comparing the efficacy, safety, and tolerability of an investigational drug versus placebo or Ropinirole in patients with early Parkinson's Disease
For Condition: Parkinson Disease
Status: Completed
Sponsor(s): Pfizer ,
Synopsis: To study the effectiveness and safety of a new dopaminergic agent for the treatment of the signs and symptoms of Parkinson's disease. Patients will be treated for 6 months with blinded study medication where neither the doctor nor the patient is aware of the treatment. After completing this study the patients will be eligible for a long term open label safety study.
Details:
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 30 Years/
Genders: Both
Protocol Entry Criteria: Other specific inclusion/exclusion criteria may apply. In order to determine eligibility, further examination by the investigator is necessary. Inclusion Criteria: Patients must meet all of the following inclusion criteria to be eligible for enrollment into the study: - Parkinson's disease of less than 7 years duration not requiring levodopa therapy. - Age greater than or equal to 30 years old. - Men or women (women of childbearing potential must have a negative pregnancy test at screen) and both must use adequate contraceptive methods. - Patients who are willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures. Exclusion Criteria: - Atypical Parkinson's disease syndromes due to drugs, metabolic disorders, encephalitis, or degenerative diseases. - Levodopa received for 1-year accumulated interval in the last two years. - Levodopa, dopamine agonist medications in the 30 days prior to baseline, some are allowed. - History of stereotaxic brain surgery. Surgery within 180 days of baseline visit which in the opinion of the investigator would negatively impact on the participation of the patient in the study. - Dementia. - History of active epilepsy within the past year. - Certain cardiac conditions. - Significant liver disease with defined laboratory criteria. - Significant kidney disease with defined laboratory criteria. - Electroconvulsive therapy in the previous 90 days. - Lactating women. - Unwillingness to use adequate contraceptive methods. - Patient participating in other investigational drug studies or having received other investigational drugs within the previous 30 days. - History of psychosis.
Total Enrollment:
Location and Contact Information:
This study is no longer recruiting
Southfield, Michigan, 48034
United States
This study is no longer recruiting
Wenatchee, Washington, 98801
United States
This study is no longer recruiting
Knoxville, Tennessee, 37916
United States
This study is no longer recruiting
Boston, Massachusetts, 02215
United States
This study is no longer recruiting
Orlando, Florida, 32806
United States
This study is no longer recruiting
Las Vegas, Nevada, 89109
United States
This study is no longer recruiting
Little Rock, Arkansas, 72205
United States
This study is no longer recruiting
Walnut Creek, California, 94598
United States
This study is no longer recruiting
Tampa, Florida, 33614
United States
This study is no longer recruiting
Glenview, Illinois, 60025
United States
This study is no longer recruiting
Kansas City, Kansas, 66160
United States
This study is no longer recruiting
Spokane, Washington, 99204
United States
This study is no longer recruiting
New York City, New York, 10032
United States
This study is no longer recruiting
Shreveport, Louisiana, 71105
United States
This study is no longer recruiting
Chicago, Illinois, 60612
United States
This study is no longer recruiting
Omaha, Nebraska, 68198-2045
United States
This study is no longer recruiting
Baltimore, Maryland, 21201
United States
This study is no longer recruiting
Asheville, North Carolina, 28801
United States
This study is no longer recruiting
Wilmington, Delaware, 19806
United States
This study is no longer recruiting
New Brunswick, New Jersey, 8901
United States
This study is no longer recruiting
Miami, Florida, 33136
United States
This study is no longer recruiting
La Jolla, California, 92037
United States
This study is no longer recruiting
Walnut Creek, California, 94596
United States
This study is no longer recruiting
Norristown, Pennsylvania, 19401
United States
This study is no longer recruiting
Loma Linda, California, 92354
United States
This study is no longer recruiting
Houston, Texas, 77030
United States
This study is no longer recruiting
New York City, New York, 10010
United States
This study is no longer recruiting
Fresno, California, 93710
United States
This study is no longer recruiting
Sellersville, Pennsylvania, 18960
United States
This study is no longer recruiting
Chicago, Illinois, 60610
United States
This study is no longer recruiting
San Francisco, California, 94109-4841
United States
This study is no longer recruiting
Ft. Lauderdale, Florida, 33308
United States
This study is no longer recruiting
Fairfield, Connecticut, 06430
United States
This study is no longer recruiting
San Francisco, California, 94143-0216
United States
This study is no longer recruiting
Tallahassee, Florida, 32308
United States
This study is no longer recruiting
Lebanon, New Hampshire, 03766
United States
This study is no longer recruiting
Springfield, Missouri, 65807
United States
This study is no longer recruiting
Great Neck, New York, 11030
United States
This study is no longer recruiting
Omaha, Nebraska, 68131-2197
United States
This study is no longer recruiting
Austin, Texas, 78756
United States
This study is no longer recruiting
Oceanside, California, 92056
United States
This study is no longer recruiting
Raleigh, North Carolina, 27607-6520
United States
This study is no longer recruiting
New Haven, Connecticut, 06510
United States
This study is no longer recruiting
Fair Oaks, California, 95628
United States
This study is no longer recruiting
Columbia, Maryland, 21044
United States
This study is no longer recruiting
Naples, Florida, 34102
United States
This study is no longer recruiting
Nashville, Tennessee, 37212-3375
United States
This study is no longer recruiting
Conyers, Georgia, 30013
United States
This study is no longer recruiting
Morristown, New Jersey, 07960
United States
This study is no longer recruiting
Bellevue, Washington, 98004
United States
This study is no longer recruiting
Maitland, Florida, 32751
United States
This study is no longer recruiting
Decatur, Georgia, 30033
United States
This study is no longer recruiting
Lake Charles, Louisiana, 70601
United States
This study is no longer recruiting
Houston, Texas, 77030
United States
This study is no longer recruiting
Los Angeles, California, 90033
United States
This study is no longer recruiting
Ridgewood, New Jersey, 07450
United States
This study is no longer recruiting
Southfield, Michigan, 48034
United States
This study is no longer recruiting
Salt Lake City, Utah, 84111
United States
This study is no longer recruiting
Syracuse, New York, 13210
United States
This study is no longer recruiting
San Antonio, Texas, 78229
United States
This study is no longer recruiting
Boston, Massachusetts, 02118
United States
This study is no longer recruiting
Hato Rey, , 00918
Puerto Rico
This study is no longer recruiting
San Luis Obispo, California, 93401
United States
This study is no longer recruiting
Burlington, Vermont, 05401
United States
This study is no longer recruiting
Irvine, California, 92618
United States
This study is no longer recruiting
Grand Rapids, Michigan, 49503
United States
This study is no longer recruiting
Mineola, New York, 11501
United States
This study is no longer recruiting
Memphis, Tennessee, 38163
United States
This study is no longer recruiting
Atlanta, Georgia, 30329
United States
This study is no longer recruiting
Little Rock, Arkansas, 72205
United States
This study is no longer recruiting
Jacksonville, Florida, 32216
United States
This study is no longer recruiting
Kansas City, Missouri, 64108
United States
This study is no longer recruiting
Upland, Pennsylvania, 19013-3995
United States
This study is no longer recruiting
Dallas, Texas, 75235
United States
This study is no longer recruiting
Milwaukee, Wisconsin, 53201
United States
This study is no longer recruiting
La Jolla, California, 92037
United States
This study is no longer recruiting
Minneapolis, Minnesota, 55455
United States
This study is no longer recruiting
Traverse City, Michigan, 49684
United States
This study is no longer recruiting
Oklahoma City, Oklahoma, 73104
United States
This study is no longer recruiting
Savannah, Georgia, 31416
United States
This study is no longer recruiting
Mount Vernon, New York, 10550
United States
This study is no longer recruiting
Tampa, Florida, 33614
United States
This study is no longer recruiting
St. Cloud, Minnesota, 56303
United States
This study is no longer recruiting
Ann Arbor, Michigan, 48104
United States
This study is no longer recruiting
Clearwater, Florida, 33761
United States
This study is no longer recruiting
Denver, Colorado, 80218
United States
This study is no longer recruiting
Southfield, Michigan, 48034
United States
This study is no longer recruiting
East Lansing, Michigan, 48848
United States
This study is no longer recruiting
Boca Raton, Florida, 33486
United States
This study is no longer recruiting
Pembroke Pines, Florida, 33028
United States
This study is no longer recruiting
Richmond, Virginia, 23294
United States
This study is no longer recruiting
Frederick, Maryland, 21702
United States
This study is no longer recruiting
Golden Valley, Minnesota, 55422
United States
This study is no longer recruiting
Salt Lake City, Utah, 84107
United States
This study is no longer recruiting
Palm Beach Gardens, Florida, 33410
United States
This study is no longer recruiting
Jacksonville, Florida, 32209
United States
Additional Information:
Study ID Numbers: 666E-CNS-0075-021;
Study Start Date:
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00036218
Other Parkinson Disease Studies:
1. Randomized Study of the Effects of Glucose on Cognition in Healthy Young and Elderly People and Parkinson's Disease Patients
2. A study comparing the efficacy, safety, and tolerability of an investigational drug versus placebo or Ropinirole in patients with early Parkinson's Disease
3. JP-1730 to Treat Parkinson's Disease
4. Molecular Epidemiology of Parkinson's Disease
5. Phase II Double Blind Controlled Trial of Nigral Grafting in Patients With Parkinson's Disease
Related Studies:
Other Parkinson Disease Clinical Trials
Other Washington Clinical Trials
Other Spokane Clinical Trials
A study comparing the efficacy, safety, and tolerability of an investigational drug versus placebo or Ropinirole in patients with early Parkinson's Disease
|
|
|
|
|
|
|
|